The 2026 ACC/AHA multisociety guideline on dyslipidaemia replaces the 2018 blood cholesterol guideline, covering evaluation, management and monitoring of high blood cholesterol, hypertriglyceridaemia and elevated lipoprotein(a).
Guideline
Blumenthal et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines